N2:MRCH1

(Reuters) -The world's first "human challenge" trial in which volunteers were deliberately exposed to the coronavirus has found that symptoms...

By Ludwig Burger and Emilio Parodi (Reuters) - As governments prepare to live with COVID-19, some are questioning how much...

By Francesco Guarascio BRUSSELS (Reuters) -The European Union is planning to buy and distribute vaccines against measles, polio, tuberculosis and...

By Manas Mishra (Reuters) - The Russian invasion of Ukraine has left drugmakers scrambling to find ways for patients enrolled...

By Riham Alkousaa BERLIN (Reuters) - Benedikt Richter, a 40-year-old teacher in the southwest German city of Kaiserslautern, long held...

By Carl O'Donnell, Francesco Guarascio and Neil Jerome Morales (Reuters) -Novavax Inc has delivered just a small fraction of the...

JAKARTA (Reuters) - Indonesia kicked off its COVID-19 booster programme for the general public on Wednesday, as the world's fourth-most-populous...

BENGALURU (Reuters) - India has approved Merck's COVID-19 pill and two more vaccines for emergency use as the world's second...

ZURICH (Reuters) - Austria should offer some healthcare staff and other key workers a fourth COVID-19 jab, the National Vaccination...

MANILA (Reuters) - The Philippines on Thursday approved emergency use of Merck & Co Inc's COVID-19 treatment pill for adult...

COPENHAGEN (Reuters) - Getting a third dose of either Pfizer-BioNTech's or Moderna's COVID-19 vaccine offers a "significant increase" in protection...

By Michael Erman (Reuters) -Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be...

(Reuters) - The upcoming New Year's Eve will mark the second anniversary of the first reported COVID-19 case in Wuhan,...

By Clara-Laeila Laudette (Reuters) - The risk of reinfection with the Omicron coronavirus variant is more than five times higher...

TOKYO (Reuters) - Japanese Prime Minister Fumio Kishida said he had spoken with the head of Pfizer Inc on Friday...

(Reuters) - Novavax's COVID-19 vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing...

By Francesco Guarascio and Panu Wongcha-um BRUSSELS/BANGKOK (Reuters) - Tens of millions of migrants may be denied COVID-19 vaccines from...

TOKYO (Reuters) - Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed...

(Reuters) - The European Union's drug regulator on Wednesday recommended that a booster dose of Johnson & Johnson's COVID-19 shot...

By Krishna N. Das NEW DELHI (Reuters) - India is struggling to export its surplus of COVID-19 vaccines as logistical...